Skip to content Skip to navigation

Hardwiring tissue-specific AAV transduction in mice through engineered receptor expression.

TitleHardwiring tissue-specific AAV transduction in mice through engineered receptor expression.
Publication TypeJournal Article
Year of Publication2023
AuthorsZengel, James, Wang Yu Xin, Seo Jai Woong, Ning Ke, Hamilton James N., Wu Bo, Raie Marina, Holbrook Colin, Su Shiqi, Clements Derek R., Pillay Sirika, Puschnik Andreas S., Winslow Monte M., Idoyaga Juliana, Nagamine Claude M., Sun Yang, Mahajan Vinit B., Ferrara Katherine W., Blau Helen M., and Carette Jan E.
JournalNat Methods
Volume20
Issue7
Pagination1070-1081
Date Published2023 Jul
ISSN1548-7105
KeywordsAnimals, Dependovirus, Gene Transfer Techniques, Genetic Therapy, Genetic Vectors, Mice, Mice, Transgenic, Transduction, Genetic, Transgenes
Abstract

The development of transgenic mouse models that express genes of interest in specific cell types has transformed our understanding of basic biology and disease. However, generating these models is time- and resource-intensive. Here we describe a model system, SELective Expression and Controlled Transduction In Vivo (SELECTIV), that enables efficient and specific expression of transgenes by coupling adeno-associated virus (AAV) vectors with Cre-inducible overexpression of the multi-serotype AAV receptor, AAVR. We demonstrate that transgenic AAVR overexpression greatly increases the efficiency of transduction of many diverse cell types, including muscle stem cells, which are normally refractory to AAV transduction. Superior specificity is achieved by combining Cre-mediated AAVR overexpression with whole-body knockout of endogenous Aavr, which is demonstrated in heart cardiomyocytes, liver hepatocytes and cholinergic neurons. The enhanced efficacy and exquisite specificity of SELECTIV has broad utility in development of new mouse model systems and expands the use of AAV for gene delivery in vivo.

DOI10.1038/s41592-023-01896-x
Alternate JournalNat Methods
PubMed ID37291262
PubMed Central IDPMC10333121
Grant ListR01 AI158808 / AI / NIAID NIH HHS / United States
R01 AI153169 / AI / NIAID NIH HHS / United States
P30 EY026877 / EY / NEI NIH HHS / United States
R01 EY024665 / EY / NEI NIH HHS / United States
K99 NS120278 / NS / NINDS NIH HHS / United States
R01 EY030151 / EY / NEI NIH HHS / United States
R01 EB028646 / EB / NIBIB NIH HHS / United States
R01 AG069858 / AG / NIA NIH HHS / United States
R01 EY032159 / EY / NEI NIH HHS / United States
R01 AG020961 / AG / NIA NIH HHS / United States
R01 AI169467 / AI / NIAID NIH HHS / United States
R01 EY025295 / EY / NEI NIH HHS / United States
I01 CX001481 / CX / CSRD VA / United States
R01 AI141970 / AI / NIAID NIH HHS / United States
T32 AI007328 / AI / NIAID NIH HHS / United States
R01 EY025225 / EY / NEI NIH HHS / United States
R01 AI130123 / AI / NIAID NIH HHS / United States
R01 AI140186 / AI / NIAID NIH HHS / United States
R01 CA219994 / CA / NCI NIH HHS / United States